Life Sciences
Attracting the Best Life Sciences Talent After Brexit
One of the reasons that the UK is a leader in life sciences has been its ability to attract, develop and retain a highly...
Unleashing The Power of Interims
Businesses are dynamic; they grow, contract, fail and succeed. Research has firmly established that this process is vital to productivity and sustained growth in...
RSA Talent Talks debut Podcast
We’re seeing some of the most exciting new therapeutics emerge from the Cell & Gene Therapy Sector, it’s happening quickly and delivering meaningful results...
Launching your first medical product in Europe? How not to fail at the first step
So, you have your first product close to launch or are even on the market in the U.S. You’re planning to take it to...
Brexit’s Uncertainty Principle
While the minutiae of the possible upcoming permutations for drug supply depending on various Brexit outcomes have been written about elsewhere, less thought has been...
Executive Interims: A creative talent solution for medtech
After attending two recent medtech industry meetings, I was struck by the scale of the two opposing forces that the sector is currently experiencing....
Who guards the Guards in life science companies?
This isn’t a new question; it’s been asked by every civilisation, from the Greeks on holding people in power to account, and the Romans...
Swiss Biotech Day 2018: Themes, trends and thoughts
Last week I attended the Swiss BioTech Annual Meeting and their 20th Anniversary. The life sciences industry is facing a fascinating new era, and...
Efficient engagement with executive search
When looking for a new role, you’ll have plenty of questions for a potential new employer. Ahead of any interview, you’ll do your due...
New talent needed for a new era of market access in the medtech industry
The last decade has seen the unprecedented growth of innovative and improved medical technologies. In turn, this has led to the development of a...
The UK is a leader in life sciences. How can we make sure that it remains No.1 in Europe?
After spending a day in mid-October at this year’s excellent UK BioScience Forum, I was left with one particular thought ringing loud and clear...
How hiring the best leaders maximizes biotech exit values
We’ve seen some major exits in the biotech market in 2017. Early in the year, in Switzerland alone, Actelion was sold to Johnson &...
Report from J.P. Morgan 2017
So, that’s the J.P. Morgan Healthcare Conference done for another year. For just a few highly energised days it felt as if nearly every...
A report from the 2018 J.P.Morgan Healthcare Conference
A quiet JPM18? I don’t think so. One thing I learned at JPM18 was that journalists see the world differently to me. There were...
Change for the better
Talent is more global now than ever. In light of the recent Brexit vote and the fact that demand for talent in Europe is...
LEAP HR Life Sciences: HR with Impact and Agile Biotechs
Last week RSA attended LEAP HR: Life Sciences in Boston, Massachusetts. From past experience we were expecting a high value event and we were not disappointed....
Serving a changing market: agile approaches to modern problems
The life sciences industry is in a state of flux. An avalanche of change demands a radical response, redefining and (potentially) confusing the roles...